Clene (CLNN) Revenue & Revenue Breakdown
Clene Revenue Highlights
Latest Revenue (Y)
$654.00K
Latest Revenue (Q)
$87.00K
Main Segment (Y)
Product
Clene Revenue by Period
Clene Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $654.00K | 38.27% |
| 2022-12-31 | $473.00K | -34.58% |
| 2021-12-31 | $723.00K | 250.97% |
| 2020-12-31 | $206.00K | 100.00% |
| 2019-12-31 | - | - |
Clene generated $654.00K in revenue during NA 2023, up 38.27% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Clene Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $87.00K | -4.40% |
| 2024-06-30 | $91.00K | 24.66% |
| 2024-03-31 | $73.00K | -57.06% |
| 2023-12-31 | $170.00K | 57.41% |
| 2023-09-30 | $108.00K | -59.85% |
| 2023-06-30 | $269.00K | 151.40% |
| 2023-03-31 | $107.00K | -54.27% |
| 2022-12-31 | $234.00K | 34.48% |
| 2022-09-30 | $174.00K | 397.14% |
| 2022-06-30 | $35.00K | 16.67% |
| 2022-03-31 | $30.00K | -84.92% |
| 2021-12-31 | $199.00K | 80.91% |
| 2021-09-30 | $110.00K | -45.27% |
| 2021-06-30 | $201.00K | -5.63% |
| 2021-03-31 | $213.00K | 634.48% |
| 2020-12-31 | $29.00K | -70.41% |
| 2020-09-30 | $98.00K | 988.89% |
| 2020-06-30 | $9.00K | -87.14% |
| 2020-03-31 | $70.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | - |
Clene generated $87.00K in revenue during Q3 2024, up -4.40% compared to the previous quarter, and up 32.34% compared to the same period a year ago.
Clene Revenue Breakdown
Clene Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|
| Royalty | $144.00K | $153.00K | $30.00K |
| Product | $316.00K | $570.00K | $176.00K |
Latest
Clene's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (68.70%), and Royalty (31.30%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Mar 24 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product | $65.00K | $44.00K | $189.00K | $130.00K | $2.00K | $7.00K | $170.00K | $63.00K | $138.00K | $199.00K |
| Royalty | $22.00K | $29.00K | $44.00K | $44.00K | $33.00K | $23.00K | $29.00K | $47.00K | $63.00K | $14.00K |
Latest
Clene's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (74.71%), and Royalty (25.29%).
Clene Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|
| Royalty | $44.00K | $44.00K | $33.00K | $23.00K | $29.00K | $47.00K | $63.00K | $14.00K |
| Product | $189.00K | $130.00K | $2.00K | $7.00K | $170.00K | $63.00K | $138.00K | $199.00K |
Latest
Clene's latest quarterly revenue breakdown by geography, as of Dec 22: Product (81.12%), and Royalty (18.88%).
Clene Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
| HOWL | Werewolf Therapeutics | $19.94M | $1.14M |
| IMNM | Immunome | $14.02M | $2.91M |
| IKNA | Ikena Oncology | $9.16M | - |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| KZR | Kezar Life Sciences | $7.00M | - |
| IPSC | Century Therapeutics | $2.23M | $791.00K |
| MNOV | MediciNova | $1.00M | - |
| CLNN | Clene | $654.00K | $87.00K |
| NGM | NGM Biopharmaceuticals | - | $165.00K |
| NKTX | Nkarta | - | - |
| NXTC | NextCure | - | - |
| GRPH | LENZ Therapeutics | - | - |
| CYT | Cyteir Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| SNSE | Sensei Biotherapeutics | - | - |
| MACK | Merrimack Pharmaceuticals | - | - |
| NUVB | Nuvation Bio | - | $727.00K |
| CSBR | Champions Oncology | - | - |